Anastasia Kosenko
About Anastasia Kosenko
Anastasia Kosenko is a Principal Scientist at Bristol Myers Squibb with over 15 years of experience in neuroimaging, neuropsychiatric research, and pharmaceutical development.
Title
Anastasia Kosenko holds the position of Principal Scientist at Bristol Myers Squibb.
Current Position at Bristol Myers Squibb
Anastasia Kosenko serves as the Principal Scientist at Bristol Myers Squibb, where she contributes her extensive research experience to the company's scientific initiatives.
Previous Roles at Bristol Myers Squibb
Prior to her current role, Anastasia Kosenko held multiple positions at Bristol Myers Squibb including Senior Scientist (2021), Research Investigator II (2019-2021), and Scientist I (2016-2019) in Redwood City, California. These roles reflect her progressive career development within the company.
Experience at Genentech
Before joining Bristol Myers Squibb, Anastasia Kosenko worked as a Senior Research Associate at Genentech from 2015 to 2016 in South San Francisco, CA. Her responsibilities included contributing to research and development projects in a leading biotechnology company.
Academic Background
Anastasia Kosenko earned a Doctor of Philosophy (PhD) from UC Irvine, completing her studies from 2010 to 2015, and a Bachelor of Science (B.S.) from UCLA, from 2006 to 2009. Her academic focus was heavily oriented towards neuroimaging and neuropsychiatric research.
Research Experience at UCLA
Anastasia Kosenko's research background includes significant contributions at UCLA, where she worked on the Neuroimaging Study of Aging and was involved in stimulant abuse and addiction research. Her roles ranged from Volunteer Research Assistant to Staff Research Associate.
Industry and Academic Research Roles
Anastasia Kosenko has over 15 years of research experience in both academic and industrial settings. Her early work involved roles at the Stimulant Abuse and Addiction Group and the Consortium for Neuropsychiatric Phenomics at UCLA, transitioning to a process technician at Allvia before her advanced roles in biotechnology and pharmaceuticals.